Distress Related to Attenuated Psychotic Symptoms: Static and Dynamic Association With Transition to Psychosis, Nonremission, and Transdiagnostic Symptomatology in Clinical High-Risk Patients in an International Intervention Trial. Issue 1 (2nd March 2020)

• Record Type: Journal Article
• Authors: Nelson, Barnaby; Yuen, Hok Pan; Amminger, G Paul; Berger, Gregor; Chen, Eric Y H; de Haan, Lieuwe; Hartmann, Jessica A; Hickie, Ian B; Lavoie, Suzie; Markulev, Connie; Mossaheb, Nilufar; Nieman, Dorien H; Nordentoft, Merete; Polari, Andrea; Riecher-Rössler, Anita; Schäfer, Miriam R; Schlögelhofer, Monika; Smesny, Stefan; Tedja, Amy; Thompson, Andrew; Verma, Swapna; Yung, Alison R; McGorry, Patrick D
• Is Part Of: Schizophrenia bulletin open. Volume 3:Issue 1(2022)
• Publication Date: 2020-03-02
• Subjects: ultra-high risk -- subjective distress -- attenuated psychotic symptoms -- transdiagnostic -- cognitive biases; Schizophrenia -- Periodicals; Schizophrenia -- Research -- Periodicals; Psychoses -- Periodicals; 616.898005
• DOI: 10.1093/schizbullopen/sgaa006
• Languages: English
• ISSNs: 2632-7899

Abstract

Abstract: This study examined whether distress in relation to attenuated psychotic symptoms (DAPS) is associated with clinical outcomes in an ultra-high risk (UHR) for psychosis sample. We also investigated whether DAPS is associated with cognitive style (attributional style and cognitive biases) and whether amount of psychosocial treatment provided is associated with reduction in DAPS. The study was a secondary analysis of the "Neurapro" clinical trial of omega-3 fatty acids. Three hundred and four UHR patients were recruited across 10 early intervention services. Data from baseline assessment, regular assessments over 12 months, and medium term follow-up (mean = 3.4 years) were used for analysis. Findings indicated: a positive association between DAPS assessed over time and transition to psychosis; a significant positive association between baseline and longitudinal DAPS and transdiagnostic clinical and functional outcomes; a significant positive association between baseline and longitudinal DAPS and nonremission of UHR status. There was no relationship between severity of DAPS and cognitive style. A greater amount of psychosocial treatment (cognitive-behavioral case management) was associated with an increase in DAPS scores. The study indicates that UHR patients who are more distressed by their attenuated psychotic symptoms are more likely to have a poorer clinical trajectory transdiagnostically. Assessment of DAPS may therefore function as a useful marker of risk for a range of poor outcomes. The findings underline the value of repeated assessment of variables and incorporation of dynamic change into predictive modeling. More research is required into mechanisms driving distress associated with symptoms and the possible bidirectional relationship between symptom severity and associated distress.